PCSC and Freenome Business Combination Update

Health
Health
Merger Vote
Merger Vote

Show Chart?

Load external content from TradingView!

*You can change or withdraw your consent at any time in the footer under Cookies.

Perceptive Capital Solutions Corp and Freenome Business Combination Update

Effectiveness of Registration Statement

New York, CA, USA - Perceptive Capital Solutions Corp (Nasdaq: PCSC), a special purpose acquisition company (SPAC), and Freenome Holdings, Inc., a developer of early cancer detection blood-based tests, have announced that the registration statement on Form S-4 for their proposed business combination was declared effective by the U.S. Securities and Exchange Commission (SEC) on June 17, 2026.

Transaction Details

... Read on — Members only

About Freenome Holdings, Inc.

Freenome is an early cancer detection company developing blood-based tests to detect cancer when it is most treatable. The company recognizes that no single technology can identify every cancer due to the disease’s inherent heterogeneity. Freenome’s approach combines a multiomics platform that analyzes multiple signals in the blood with artificial intelligence and machine learning to tune into cancer’s subtlest clues, even at the earliest stages of the disease.

View Company Details

More FRNM News

SPAC IPO Calendar
SPAC IPO Events
Scroll to Top